University of Melbourne

The University of Melbourne, established in 1853, is a prominent public institution in Australia recognized for its contributions to research, learning, and community engagement. It consistently ranks among the top universities globally, being the highest-ranked in Australia and 33rd worldwide according to the Times Higher Education World University Rankings for 2014-2015. The university operates a non-profit endowment fund that manages philanthropic contributions from donors, supporting its educational and research missions. Additionally, the University of Melbourne Endowment Fund functions as an early-stage venture capital fund, focusing on investments in sectors such as information technology services, pharmaceuticals, biotechnology, technology, media and telecommunications, and e-commerce.

Geoffrey Donnan

Director FNI

6 past transactions

AIBUILD

Seed Round in 2021
Proudly partnered with The University of Melbourne and the Australian Research Council, AIBUILD is a big data and innovative solutions provider founded in 2017 as an emerging Australian startup. AIBUILD positions itself as a professional industry innovative solutions provider. Over the last three years in Australia, we have developed big data and software solutions for clients in industries ranging from the real estate industry to education and research, including: JH Market - Multi-warehouse solutions + distributed system for large industrial electrical products supplier (JinHang Lighting & Electrical) MyMart – Innovative e-commerce + smart supply chain solution for large Asian groceries (KT Mart) HousePro – Innovative real-time VR+AI matching system in global real-estate industry Crowdfunding platform - ARC IH150100006 (The University of Melbourne, Monash University, Australian Research Council) Otaro - Real-time online panorama/VR teaching platform (The University of Melbourne) A smart wind-driven natural ventilation system for buildings (The University of Melbourne, RMIT) We aim to ensure the widespread use of Artificial Intelligence Technology in Australia by helping our enterprise clients reduce costs and Improve consistency in their processes with Artificial Intelligence (AI) and virtual reality (VR) technology. We remain firmly committed to providing unparalleled quality design and impeccable service to ensure we meet the ranging needs of all our customers.

Synchron

Series B in 2021
Synchron Inc., based in San Mateo, California, is a developer of advanced medical devices that facilitate brain-computer interfaces. The company specializes in an implantable stentrode, a minimally invasive device that is delivered to the brain via catheter. This device is equipped with electrode arrays that record neuron signals and interpret brain activity, allowing individuals with motor impairments to regain control over digital devices, prosthetics, and other assistive technologies through thought alone. By bridging the gap between neural signals and device operation, Synchron aims to enhance the quality of life for patients with mobility challenges.

AIBUILD

Pre Seed Round in 2020
Proudly partnered with The University of Melbourne and the Australian Research Council, AIBUILD is a big data and innovative solutions provider founded in 2017 as an emerging Australian startup. AIBUILD positions itself as a professional industry innovative solutions provider. Over the last three years in Australia, we have developed big data and software solutions for clients in industries ranging from the real estate industry to education and research, including: JH Market - Multi-warehouse solutions + distributed system for large industrial electrical products supplier (JinHang Lighting & Electrical) MyMart – Innovative e-commerce + smart supply chain solution for large Asian groceries (KT Mart) HousePro – Innovative real-time VR+AI matching system in global real-estate industry Crowdfunding platform - ARC IH150100006 (The University of Melbourne, Monash University, Australian Research Council) Otaro - Real-time online panorama/VR teaching platform (The University of Melbourne) A smart wind-driven natural ventilation system for buildings (The University of Melbourne, RMIT) We aim to ensure the widespread use of Artificial Intelligence Technology in Australia by helping our enterprise clients reduce costs and Improve consistency in their processes with Artificial Intelligence (AI) and virtual reality (VR) technology. We remain firmly committed to providing unparalleled quality design and impeccable service to ensure we meet the ranging needs of all our customers.

Apromore

Series A in 2020
Apromore is a collaborative business process analytics platform that offers comprehensive process mining capabilities. The platform integrates open-source technology with an intuitive design and various data connections, facilitating the adoption of process mining. It enables organizations to uncover inefficiencies, friction points, and compliance violations within their processes, thus enhancing decision-making and unlocking value from transactional data. Apromore also features an authoring environment for business process models, supported by an enterprise process model repository, allowing teams to leverage advanced data science techniques in a no-code environment. This combination of tools fosters digital transparency and operational excellence, empowering business teams to improve their processes effectively.

Clarity Pharmaceuticals

Venture Round in 2016
Clarity Pharmaceuticals Pty Ltd is a clinical-stage company based in Sydney, Australia, specializing in radiopharmaceutical technology for the treatment of cancer, cardiovascular diseases, and fibrosis. The company develops targeted therapies, including SARTATE, which is designed for various cancers such as neuroblastoma in children and meningioma and neuroendocrine tumors in adults. Clarity's innovative platform technology allows for the radiolabeling of antibodies, facilitating personalized medicine through PET imaging. This technology provides crucial data on whether drugs effectively target the disease in individual patients, enabling a tailored therapeutic approach. Additionally, Clarity offers preclinical PET imaging and clinical research services, supporting the drug development pipeline for novel therapies on a global scale. Established in 2010, Clarity Pharmaceuticals is at the forefront of advancements in precision medicine and theranostic products.

Omny Studio

Grant in 2012
Omny Studio is a comprehensive on-demand audio management solution designed for content creators, including radio stations and podcasters. The platform facilitates the distribution, analysis, monetization, and archiving of audio content, enabling users to focus on producing high-quality material for their audiences. By offering seamless integration with live streaming services, content management systems, and advertising platforms, Omny Studio streamlines the audio publishing workflow. This software-as-a-service solution helps creators grow their audience while reducing production costs, ultimately enhancing their ability to monetize their content effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.